New PET tracer for brain imaging tested in humans for first time

NCT ID NCT03347331

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This early-phase study tested a new radioactive tracer called [18F]F13640 in 20 healthy volunteers. The tracer is designed to attach to specific receptors in the brain and be seen on a PET scan. The goal was to validate the imaging method and check how reproducible the results are, not to treat any disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

[18F]F13640 (a radioactive tracer for PET scans)

What this could lead to

If successful, this could provide a new way to image brain receptors, potentially aiding research into neurological conditions.

What could go wrong

This is a very early, small study in healthy people only. It is designed to test the imaging method, not to treat any disease, so direct patient benefits are far off.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospices Civils de Lyon

    Bron, France